Latest filing published 09 Aug 2013 for Oncotelic Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -9.6%Entry US$2.80 · Close at T+365 US$2.53
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter Langecker: trading record in brief
Peter Langecker is a declared insider of Oncotelic Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 25 June 2013 to 8 August 2013, the count stands at 3 filings.
On the market, this insider has only ever bought: 2 purchases, €11k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
The record was last updated on 9 August 2013 with a share grant in Oncotelic Therapeutics, Inc. The last insider purchase was made public on 1 July 2013, 4,879 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter Langecker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 72,993 shares0Common Stock, $0.01 par value per shareSEC:0001181431-13-044022:0
- 3,000 shares@ US$2.75Common Stock, par value $0.01 per shareSEC:0001181431-13-037361:0Canonical exit: 26 Sept 2013 (T+90)
- 2,000 shares@ US$2.79Common Stock, par value $0.01 per shareSEC:0001181431-13-036819:0Canonical exit: 23 Sept 2013 (T+90)
3 of 3 declarations
